http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102389415-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16ae182fcb6f2fb6fb91ba7cba30682a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
filingDate | 2008-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d978d3606a800a81f3fecaae1c427560 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03138ad7b4851a6ce365e687420b6479 |
publicationDate | 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102389415-B |
titleOfInvention | Application of iridoid compounds to preparation of medicine for treating benign prostatic hyperplasia |
abstract | The invention discloses an application of iridoid compounds to preparation of a medicine for treating benign prostatic hyperplasia. The iridoid compounds are compounds D and derived from valerianaceae plants which have an ancient officinal history and good safety. Compared with the original jatamans valeriana rhizome extract, the iridoid compounds more explicit medicine effect materials, and provide possibility for the preparation of the medicine for treating the benign prostatic hyperplasia, with better market prospect. |
priorityDate | 2008-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.